Compounded tirzepatide is not FDA approved, so its safety rests on three things you can check: a state-licensed 503A pharmacy, a licensed clinician who reviewed your health, and a vial label that says exactly what is inside. The drug itself carries the same warnings as Zepbound and Mounjaro. The extra risk with compounding comes from the source, not the molecule. Start with our tirzepatide guide if you are new to the drug.
Key takeaways
- The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. That is the core difference from Zepbound and Mounjaro.
- The FDA's concerns with unapproved GLP-1 drugs include dosing errors from vials, products from unlicensed sellers, and ingredients that differ from the approved drug.
- You can look up a pharmacy on its state board of pharmacy website. You can look up a prescriber on the state medical, nursing or physician assistant board.
- Compounded tirzepatide is still available through licensed prescribers and pharmacies when a clinician decides it is right for a patient.
- Every warning on the branded label applies to the molecule in any form, from the thyroid boxed warning to pancreatitis and gallbladder disease.
What "compounded tirzepatide" means and why it is not FDA approved
The FDA describes compounding as combining, mixing or altering ingredients to make a medication for one patient. A compounding pharmacy buys tirzepatide as a raw ingredient. It prepares the drug in sterile solution. It then fills a vial labeled for one named person under a prescription. Because each vial is made for one person, not under an approved application, the FDA does not test it. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro.
Zepbound and Mounjaro are not compounded. Eli Lilly makes them under FDA-approved applications. Every batch is made to the specifications in those applications. So, is Zepbound a compound drug? No. Zepbound is the branded product. A compound is a pharmacy-made alternative that uses the same active ingredient name.
What the FDA says about unapproved GLP-1 drugs
The FDA keeps a page on its concerns with unapproved GLP-1 drugs used for weight loss. Its main points, in plain terms:
Get compounded tirzepatide, first month $149, then $239 per month, or $214 per month with Subscribe & Save
Free provider review, personalized dosing, and ongoing support included.
Start Free Assessment →- Compounded drugs are not FDA approved. The agency does not verify their safety, effectiveness or quality before they are sold.
- The FDA has received reports of adverse events tied to compounded GLP-1 products. Some involve dosing errors when people draw up doses from vials or misread units.
- Some products use a different form of the active ingredient, such as a salt form, than the approved drug uses.
- Products sold online without a prescription, or labeled for research use, sit outside the legal supply chain. They may not contain what the label says.
The agency does not publish a safety rate for licensed compounded tirzepatide. Neither does this page. What the FDA's list gives you is a set of things to rule out.
Is compounded tirzepatide safe? A checklist you can run
| What to check | How to check it | What a good answer looks like |
|---|---|---|
| Pharmacy license. | Search the pharmacy name on its home state's board of pharmacy license lookup. | An active license. A physical address that matches. |
| Pharmacy type. | Ask whether it is a state-licensed 503A compounding pharmacy. | Yes. It compounds for named patients under prescriptions. |
| Prescriber license. | Search the prescriber's name on the state medical, nursing or physician assistant board. | An active license in your state. A real health review before the prescription. |
| Vial label. | Read it when the package arrives. | Your name. The drug. The concentration, such as 10 mg/mL. A beyond-use date. Storage directions. The pharmacy's name and address. |
| Certificate of analysis. | Ask the pharmacy whether it gets one for the tirzepatide it uses. | Yes, from the ingredient supplier, with identity and purity tests. |
| Cold-chain shipping. | Check the package on arrival. | Insulated packaging with a cold pack. The vial is cool to the touch. |
| Prescription rule. | Try to skip the health questions. | You cannot. No prescription, no medication. |
Source: FDA, Compounding and the FDA: Questions and Answers; FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss; Zepbound prescribing information for label and storage items.
What a certificate of analysis is, and is not
A certificate of analysis (COA) is a lab report for a batch of material. It usually covers identity (is it tirzepatide?), purity (how much of the batch is tirzepatide?), and sometimes contaminants. Licensed pharmacies get COAs for the raw ingredients they buy. A COA is useful. But it describes the ingredient before compounding, not the finished vial you receive. It also cannot replace a pharmacy license, because anyone can post a PDF. Treat a COA as one item on the checklist, not the whole answer.
What is in the vial: additives like niacinamide and B12
Some compounded tirzepatide products include an additive. Common ones are niacinamide (a form of vitamin B3) and cyanocobalamin (a form of vitamin B12). Neither is in Zepbound or Mounjaro. No trial in our verified list tested tirzepatide with either additive. The additive does not change how tirzepatide works. It changes what else you are injecting. The label on your vial should list every ingredient. If it does not, ask the pharmacy for the formula before you inject. Our tirzepatide with niacinamide page covers that combination.
The risks that belong to the drug, not the pharmacy
Even a perfectly made vial carries every risk on the branded label. Know these before you start.
- Boxed warning. Thyroid C-cell tumors were seen in rats. The human risk is unknown. Do not use tirzepatide if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
- Warnings and precautions. Severe gastrointestinal disease. Acute kidney injury from dehydration after vomiting or diarrhea. Acute gallbladder disease. Acute pancreatitis. Low blood sugar when combined with insulin or sulfonylureas. Hypersensitivity reactions. Diabetic retinopathy complications in people with type 2 diabetes. Pulmonary aspiration during general anesthesia or deep sedation. Never sharing a Zepbound KwikPen between patients.
- Pregnancy. Tirzepatide may cause fetal harm based on animal studies. Tell your prescriber if you are pregnant or planning to be.
- Common side effects. The Zepbound label lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, burping, hair loss and reflux. In SURMOUNT-1, 4.3% to 7.1% of participants on tirzepatide stopped because of adverse events, versus 2.6% on placebo.
A prescriber who does not ask about these before prescribing is a red flag, no matter how good the pharmacy is.
Can you still get compounded tirzepatide?
Yes. You can get it through licensed prescribers and state-licensed 503A pharmacies, when a clinician decides it is right for you. The FDA declared the tirzepatide shortage resolved on December 19, 2024. That changed the rules for compounders who were making copies of the branded product during the shortage. Our tirzepatide shortage status page explains what that meant. Tirzepatide is never sold over the counter. Any product sold without a prescription is not a lawful medication.
What this means for compounded tirzepatide
Here is how FormBlends answers the checklist. Prescriptions are written by independent, state-licensed clinicians (MD, DO, NP or PA) of Recess MD LLC, a medical group separate from Form Blends LLC, after an online health assessment. Medication is made by state-licensed 503A compounding pharmacies: Greenwich RX in Texas, The DrugStore on East State in Ohio, and Chemistry Rx in Pennsylvania. It ships cold-chain with injection supplies included. If the clinician does not prescribe, the charge is refunded. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro. Prices are on the pricing page. The assessment is the first step.
Frequently Asked Questions
Is compounded tirzepatide safe?
It depends on the source. Compounded tirzepatide is not FDA approved, so the checks that matter are a licensed 503A pharmacy, a licensed prescriber who reviewed your health, and a complete vial label. The molecule carries the same warnings as Zepbound and Mounjaro. Read them before you start.
Does compounded tirzepatide work?
No trial in our verified sources has tested a compounded product, so no one can quote a result for it. The SURMOUNT trials tested the branded injectable. There, 15 mg produced a -20.9% mean weight change over 72 weeks. A correctly made compounded vial holds the same molecule, but that is a statement about chemistry, not a trial result.
Is compounded tirzepatide the same as Zepbound?
No. They share the active ingredient name. Zepbound is an FDA-approved product made by Eli Lilly. Compounded tirzepatide is a pharmacy-made product the FDA has not reviewed. They are not interchangeable, and a compounded product may include additives or a different salt form.
Can you get tirzepatide over the counter?
No. Tirzepatide in any form requires a prescription. A website that sells it with no health questions and no prescriber is selling outside the legal supply chain. That is one of the FDA's stated concerns.
What does "compound tirzepatide" mean?
It means tirzepatide prepared by a pharmacist for one patient from a prescription, rather than made under an FDA-approved application. The FDA's compounding questions and answers page describes the practice and its limits.
What is tirzepatide with cyanocobalamin?
It is compounded tirzepatide with vitamin B12 (cyanocobalamin) added to the vial. The B12 is not part of the branded product. It has not been tested with tirzepatide in any trial we cite. The vial label should list it, and your prescriber should know you are getting it.
Sources
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration.
- Compounding and the FDA: Questions and Answers, U.S. Food and Drug Administration.
- Zepbound prescribing information, DailyMed, revised 08/2026.
- Mounjaro prescribing information, DailyMed, revised 08/2026.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
Next steps
Compare the two products line by line in compounded tirzepatide vs Mounjaro, or see what to avoid in gray market tirzepatide. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician before starting or changing any medication. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →